logo

$5 And Under

Share SHARE

Carver Bancorp Inc. (CARV) has been climbing since the open of trade Friday. The stock has accelerated to the upside in the last 10 minutes on increased volume and is currently higher by 2.21 at $6.20. Carver Bancorp has surged past resistance and has set a new high for the year.

Pernix Therapeutics (PTX) has spiked sharply to the upside in early trade Friday and is currently higher by 1.23 at $4.53 on above average volume. Pernix Therapeutics has broken out to nearly a 6-month high and has re-crossed its 200-day moving average.

Soligenix Inc. (SNGX) announced Wednesday morning that results from its ricin toxin vaccine development program will be presented at the 20th Annual Conference on Vaccine Research. Soligenix gapped open sharply higher this morning and has continued to rise on above average volume. The stock is now...

GNC Holdings (GNC) reported first quarter EPS of $0.35 Tuesday morning, down from $0.69 a year ago. Street expectations were for EPS of $0.34. GNC Holdings gapped up sharply Tuesday and climbed higher around midday. The stock finished up by 1.79 at $9.03 on the highest volume of the year. GNC leaped...

Interpace Diagnostics Group (IDXG) announced Tuesday morning that UnitedHealthcare has agreed to cover the company's ThyraMIR test, which is used to assess indeterminate thyroid nodule fine needle aspirate biopsies. Interpace Diagnostics gapped up sharply Tuesday and has continued to rise on above...

Cleveland BioLabs (CBLI) announced Monday morning that the European Medicines Agency has accepted its pediatric investigation plan for entolimod as a medical radiation countermeasure. The FDA has also finished its review of a side-by-side analytical comparison of two formulations of entolimod. The...

Cleveland BioLabs (CBLI) gapped up at the open Monday and has risen sharply in early trade on the highest volume of the year. Shares are now up 0.83 at $2.39. The stock has surged to an 8-month high. Cleveland BioLabs announced this morning that the European Medicines Agency has accepted its pediatric...

Fibrocell Science Inc. (FCSC) has been rising since the open of trade Thursday and is now up 0.38 at $2.53. The stock has climbed to a 1-month high and has re-crossed its 200-day moving average. Fibrocell Science announced this morning that its CEO will present at the 7th Annual World Orphan Drug...

Adeptus Health Inc. (ADPT) has been rising sharply since the open of trade Wednesday and is now up 1.92 at $3.00 on above average volume. Adeptus Health has broken out of a narrow trading range at the lows of the year and has set a 1-month high.

Novan Inc. (NOVN) announced Wednesday morning that its Phase 2 study of SB208 gel demonstrated a statistically significant effect in patients with athlete's foot. Novan gapped open sharply higher Wednesday, but has since pared its gain a bit in early trade. The stock is now up 1.80 at $7.00 on above...

Thinly traded Payment Data Systems (PYDS) has been rising steadily since the open of trade Tuesday and is currently higher by 1 point at $2.27. Trading volume has already hit over a 6-month high. Payment Data Systems has surged to a 5-month high and has re-crossed both its 50 and 200-day moving averages.

OncoMed Pharmaceuticals Inc. (OMED) announced Monday morning that its Phase 2 trial of demcizumab in combination with Abraxane plus gemcitabine, in previously untreated patients with metastatic pancreatic cancer, did not meet the primary endpoint of progression-free survival. Bayer Pharma has also...

OncoMed Pharmaceuticals Inc. (OMED) announced Monday morning that its Phase 2 trial of demcizumab in combination with Abraxane plus gemcitabine, in previously untreated patients with metastatic pancreatic cancer, did not meet the primary endpoint of progression-free survival. Bayer Pharma has also...

Plug Power Inc. (PLUG) announced Wednesday morning that it reached an agreement with Amazon (AMZN). Amazon will begin powering its industrial equipment at select fulfillment center locations by utilizing Plug Power fuel cells and hydrogen technology. Plug Power gapped open sharply higher Wednesday,...

Benitec Biopharma (BNTC) announced Tuesday morning that initial pre-clinical efficacy results of the OPMD program have been published in Nature Communications. Benitec Biopharma gapped up at the open Tuesday and has continued to rise steadily on above average volume. The stock is now up 1.75 at $4.80...

Follow RTT